Han Zhang

Publication Activity (10 Years)

Years Active: 2021-2024
Publications (10 Years): 7

Top Topics

Signaling Pathway

Top Venues

This page only lists publications with an associated author ORCID identifier.

Publications

Han Zhang, Liru Li, Zijian Zhang, Shiqi Gao, Mingzhe Yang, Wenjie Ma, Hongbin Li, Wenhui Zhao, Huike Yang, Yue Zhang, Shu Zhao
Pyroptotic macrophages promote proliferation and chemotherapy resistance of peripheral T-cell lymphoma via TLR4 signaling pathway. Cancer science 115 (7) (2024)
Han Zhang, Liru Li, Zijian Zhang, Shiqi Gao, Mingzhe Yang, Wenjie Ma, Hongbin Li, Wenhui Zhao, Huike Yang, Yue Zhang, Shu Zhao
Pyroptotic macrophages promote proliferation and chemotherapy resistance of peripheral T-cell lymphoma via TLR4 signaling pathway. Cancer science 115 (7) (2024)
Han Zhang, Liru Li, Zijian Zhang, Shiqi Gao, Mingzhe Yang, Wenjie Ma, Hongbin Li, Wenhui Zhao, Huike Yang, Yue Zhang, Shu Zhao
Pyroptotic macrophages promote proliferation and chemotherapy resistance of peripheral T-cell lymphoma via TLR4 signaling pathway. Cancer science 115 (7) (2024)
Han Zhang, Liru Li, Zijian Zhang, Shiqi Gao, Mingzhe Yang, Wenjie Ma, Hongbin Li, Wenhui Zhao, Huike Yang, Yue Zhang, Shu Zhao
Pyroptotic macrophages promote proliferation and chemotherapy resistance of peripheral T-cell lymphoma via TLR4 signaling pathway. Cancer science 115 (7) (2024)
Han Zhang, Liru Li, Zijian Zhang, Shiqi Gao, Mingzhe Yang, Wenjie Ma, Hongbin Li, Wenhui Zhao, Huike Yang, Yue Zhang, Shu Zhao
Pyroptotic macrophages promote proliferation and chemotherapy resistance of peripheral T-cell lymphoma via TLR4 signaling pathway. Cancer science (2024)
Han Zhang, Liru Li, Zijian Zhang, Shiqi Gao, Mingzhe Yang, Wenjie Ma, Hongbin Li, Wenhui Zhao, Huike Yang, Yue Zhang, Shu Zhao
Pyroptotic macrophages promote proliferation and chemotherapy resistance of peripheral T-cell lymphoma via TLR4 signaling pathway. Cancer science 115 (7) (2024)
Han Zhang, Jinlu Wang, Jingtong Li, Xiaoping Zhou, Lei Yin, Yiran Wang, Yucui Gu, Xingjian Niu, Yue Yang, Hongfei Ji, Qingyuan Zhang
HMGB1 is a key factor for tamoxifen resistance and has the potential to predict the efficacy of CDK4/6 inhibitors in breast cancer. Cancer science 112 (4) (2021)